StockData
Castle Biosciences Inc logo

Castle Biosciences Inc (CSTL) bonds

CSTLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/304% below fair value
$32.98+0.23 (+0.70%)

Close on Nov 17, 2026Market cap $1.01BP/E –Yield 0.00%

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$10.08M
$4.17M due within a year
Net debt
-$67.91M
After $77.99M of cash
Implied interest rate
0.86%
FY2025 interest ÷ average debt
Interest coverage
-497.8×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2019

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Castle Biosciences's 10-Q for the period ended Jun 30, 2026

Castle Biosciences's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
2024 Loan and Security Agreement$25.00M

See a number that looks wrong?